Three-dimensional ultrasound developer Life Imaging Systems has received a $3 million (Canadian) private placement from a Canadian investment firm. The cash infusion is part of a total investment of $8 million made in Life by Sofinov, Societé
Three-dimensional ultrasound developer Life Imaging Systems has received a $3 million (Canadian) private placement from a Canadian investment firm. The cash infusion is part of a total investment of $8 million made in Life by Sofinov, Societé financière dinnovation, of Montreal, Quebec.
Life plans to use the money for product commercialization and market expansion purposes, according to the company. Life, of London, Ontario, recently assembled a marketing team and developed a new corporate identity. It plans to display its products at this years Radiological Society of North America meeting.
Lifes L3D family of products are targeted at ultrasound OEMs and enable users to assemble 3-D ultrasound images from 2-D scans.
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
Study Shows Enhanced Diagnosis of Coronary Artery Stenosis with Photon-Counting CTA
July 10th 2025In a new study comparing standard resolution and ultra-high resolution modes for patients undergoing coronary CTA with photon-counting detector CT, researchers found that segment-level sensitivity and accuracy rates for diagnosing coronary artery stenosis were consistently > 89.6 percent.
FDA Expands Approval of MRI-Guided Ultrasound Treatment for Patients with Parkinson’s Disease
July 9th 2025For patients with advanced Parkinson’s disease, the expanded FDA approval of the Exablate Neuro platform allows for the use of MRI-guided focused ultrasound in performing staged bilateral pallidothalamic tractotomy.